Zobrazeno 1 - 10
of 53
pro vyhledávání: '"KL Pogue-Geile"'
Autor:
Peter C. Lucas, Soonmyung Paik, Norman Wolmark, Nan Song, KL Pogue-Geile, Ashok Srinivasan, Patrick G. Gavin, Corey Lipchik, Huichen Feng, Rim S. Kim, Ying Wang, Joseph P. Costantino, Samuel A. Jacobs
Publikováno v:
Cancer Research. 79:P3-10
Background: We previously described a predictive signature for trastuzumab benefit which was validated in the adjuvant setting in an independent cohort within NSABP B-31 (the 8-gene signature) (Pogue-Geile et al JNCI, 2013) and in Alliance/NCCTG N983
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::741a74eb82ca42fe2af62b394b7f5f94
https://doi.org/10.1158/1538-7445.sabcs18-p3-10-04
https://doi.org/10.1158/1538-7445.sabcs18-p3-10-04
Autor:
Samuel A. Jacobs, S. Rim Kim, KL Pogue-Geile, JP Michel, Emma Langley, Ashok Srinivasan, Phillip Kim, Gary Meyer, C Lipchick, Patrick G. Gavin, Huichen Feng
Publikováno v:
Cancer Research. 77:P1-07
The NSABP FB-7 trial enrolled HER2-positive breast cancer patients (pts) with locally advanced disease who were randomly assigned to trastuzumab (T) or neratinib (N) or the combination (T+N) with weekly paclitaxel (P) followed by standard AC. A total
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c08606c7a5c63cb965cbd1774df918ef
https://doi.org/10.1158/1538-7445.sabcs16-p1-07-12
https://doi.org/10.1158/1538-7445.sabcs16-p1-07-12
Autor:
Rebecca J. Nagy, Marc Buyse, A Montero, Brian F. Kiesel, Mohamad Adham Salkeni, Jacinta Abraham, Laura M Adamson, KL Pogue-Geile, William M. Sikov, Jan H. Beumer, Ashok Srinivasan, WA Razaq, Shannon Puhalla, Samuel A. Jacobs, Carmen J. Allegra
Publikováno v:
Cancer Research. 79:PD3-04
Background: In this phase Ib study, the activity of T-DM1 plus N was assessed in patients (pt) previously treated with trastuzumab, pertuzumab, and a taxane (H+P+T). Several mechanisms of resistance have been hypothesized in pts progressing following
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12c0ab76c2b786a352137a22a8e41ea0
https://doi.org/10.1158/1538-7445.sabcs18-pd3-04
https://doi.org/10.1158/1538-7445.sabcs18-pd3-04
Autor:
Rebecca J. Nagy, Ashok Srinivasan, Samuel A. Jacobs, KL Pogue-Geile, Richard B. Lanman, Patrick G. Gavin, Rekha Pal, Peter C. Lucas, AmirAli Talasaz, S. Rim Kim, Carmen J. Allegra
Publikováno v:
Cancer Research. 77:5684-5684
Background: FC-7 is a phase Ib study hypothesizing that dual ERBB blockade (neratinib and cetuximab) could overcome an acquired resistance mechanism to anti-EGFR tx in KRAS/NRAS/BRAF/PI3KCA wild type (wt) mCRC patients (pts). Previously we demonstrat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74cf2779e73b97ee2416e39bb56d3472
https://doi.org/10.1158/1538-7445.am2017-5684
https://doi.org/10.1158/1538-7445.am2017-5684
Autor:
Chumsri S; Mayo Clinic Florida, Jacksonville, FL., Pai T; Mayo Clinic Florida, Jacksonville, FL., Ma Y; Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville, FL., Li Z; Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville, FL., Gil A; Mayo Clinic Florida, Jacksonville, FL., Moreno-Aspitia A; Mayo Clinic Florida, Jacksonville, FL., Colon-Otero G; Mayo Clinic Florida, Jacksonville, FL., Pogue-Geile KL; NRG Oncology/NSABP Foundation, Inc., Pittsburgh, PA., Rasgoti P; NRG Oncology/NSABP Foundation, Inc., Pittsburgh, PA.; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.; UPMC Magee-Women's Hospital, Pittsburgh, PA., Paik S; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Perez EA; Mayo Clinic Florida, Jacksonville, FL., Thompson EA; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL.
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2024 Aug 26; Vol. 22 (7), pp. 463-468. Date of Electronic Publication: 2024 Aug 26.
Autor:
Jacobs SA; NSABP Foundation, Pittsburgh, PA, USA. jacobssa1945@gmail.com., Wang Y; NSABP Foundation, Pittsburgh, PA, USA., Abraham J; NSABP Foundation, Pittsburgh, PA, USA.; Cleveland Clinic, Taussig Cancer Institute, Weston, Cleveland, OH, USA., Feng H; NSABP Foundation, Pittsburgh, PA, USA., Montero AJ; NSABP Foundation, Pittsburgh, PA, USA.; Cleveland Clinic, Taussig Cancer Institute, Weston, Cleveland, OH, USA.; University Hospitals/Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Lipchik C; NSABP Foundation, Pittsburgh, PA, USA., Finnigan M; NSABP Foundation, Pittsburgh, PA, USA., Jankowitz RC; NSABP Foundation, Pittsburgh, PA, USA.; University of Pittsburgh, Pittsburgh, PA, USA.; University of Pennsylvania Perelman School of Medicine, State College, Philadelphia, PA, USA., Salkeni MA; NSABP Foundation, Pittsburgh, PA, USA.; National Institutes of Health, Washington, DC, USA.; Virginia Cancer Specialists, Fairfax, VA, USA., Maley SK; NSABP Foundation, Pittsburgh, PA, USA., Puhalla SL; NSABP Foundation, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Piette F; International Drug Development Institute, Louvain-la-Neuve, Belgium., Quinn K; Guardant Health, Redwood City, CA, USA., Chang K; Guardant Health, Redwood City, CA, USA., Nagy RJ; Guardant Health, Redwood City, CA, USA., Allegra CJ; NSABP Foundation, Pittsburgh, PA, USA.; University of Florida Health, Gainesville, FL, USA., Vehec K; NSABP Foundation, Pittsburgh, PA, USA., Wolmark N; NSABP Foundation, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Lucas PC; NSABP Foundation, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Srinivasan A; NSABP Foundation, Pittsburgh, PA, USA.; Autism Impact Fund, Pittsburgh, PA, USA., Pogue-Geile KL; NSABP Foundation, Pittsburgh, PA, USA.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2024 May 24; Vol. 26 (1), pp. 83. Date of Electronic Publication: 2024 May 24.
Autor:
Chen L; Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA., Wang Y; NSABP/NRG Oncology, Pittsburgh, PA., Cai C; Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA., Ding Y; NRG Oncology Statistics and Data Management Center, Pittsburgh, PA.; Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA., Kim RS; NSABP/NRG Oncology, Pittsburgh, PA.; AstraZeneca, Oncology Translational Medicine, Gaithersburg, MD., Lipchik C; NSABP/NRG Oncology, Pittsburgh, PA., Gavin PG; NSABP/NRG Oncology, Pittsburgh, PA.; AstraZeneca Respiratory and Immunology, Gaithersburg, MD., Yothers G; NRG Oncology Statistics and Data Management Center, Pittsburgh, PA.; Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA., Allegra CJ; Department of Medicine, University of Florida Health, Gainesville, FL., Petrelli NJ; Helen F. Graham Cancer Center and Research Institute at Christiana Care, Newark, DE., Suga JM; Kaiser Permanente Oncology Clinical Trials, KP NCI Community Oncology Research Program (NCORP), Vallejo, CA., Hopkins JO; Novant Health Forsyth Medical Cancer Institute/Southeast Clinical Oncology Research NCORP, Kernersville, NC., Saito NG; Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN., Evans T; UPMC Hillman Cancer Center, Pittsburgh, PA., Jujjavarapu S; Illinois CancerCare, P.C./Heartland Cancer Research NCORP, Peoria, IL., Wolmark N; NSABP/NRG Oncology, Pittsburgh, PA.; UPMC Hillman Cancer Center, Pittsburgh, PA.; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA., Lucas PC; NSABP/NRG Oncology, Pittsburgh, PA.; UPMC Hillman Cancer Center, Pittsburgh, PA.; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA., Paik S; NSABP/NRG Oncology, Pittsburgh, PA.; Yonsei University College of Medicine, Yonsei Biomedical Research Institute, Seoul, Republic of South Korea., Sun M; UPMC Hillman Cancer Center, Pittsburgh, PA.; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.; DeepRx Inc, Pittsburgh, PA., Pogue-Geile KL; NSABP/NRG Oncology, Pittsburgh, PA., Lu X; Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA.; DeepRx Inc, Pittsburgh, PA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 May 01; Vol. 42 (13), pp. 1520-1530. Date of Electronic Publication: 2024 Feb 05.
Autor:
Jacobs SA; NSABP Foundation, Pittsburgh, PA, USA. jacobssa1945@gmail.com., Wang Y; NSABP Foundation, Pittsburgh, PA, USA., Abraham J; NSABP Foundation, Pittsburgh, PA, USA.; Cleveland Clinic, Weston/Taussig Cancer Institute, Cleveland, OH, USA., Feng H; NSABP Foundation, Pittsburgh, PA, USA., Montero AJ; NSABP Foundation, Pittsburgh, PA, USA.; Cleveland Clinic, Weston/Taussig Cancer Institute, Cleveland, OH, USA.; University Hospitals/Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Lipchik C; NSABP Foundation, Pittsburgh, PA, USA., Finnigan M; NSABP Foundation, Pittsburgh, PA, USA., Jankowitz RC; NSABP Foundation, Pittsburgh, PA, USA.; University of Pittsburgh, Pittsburgh, PA, USA.; University of Pennsylvania Perelman School of Medicine, State College, PA, USA., Salkeni MA; NSABP Foundation, Pittsburgh, PA, USA.; National Institutes of Health, Washington, DC, USA.; Virginia Cancer Specialists, Fairfax, VA, USA., Maley SK; NSABP Foundation, Pittsburgh, PA, USA., Puhalla SL; NSABP Foundation, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Piette F; International Drug Development Institute, Louvain-la-Neuve, Belgium., Quinn K; Guardant Health, Redwood City, CA, USA., Chang K; Guardant Health, Redwood City, CA, USA., Nagy RJ; Guardant Health, Redwood City, CA, USA., Allegra CJ; NSABP Foundation, Pittsburgh, PA, USA.; University of Florida Health, Gainesville, FL, USA., Vehec K; NSABP Foundation, Pittsburgh, PA, USA., Wolmark N; NSABP Foundation, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Lucas PC; NSABP Foundation, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Srinivasan A; NSABP Foundation, Pittsburgh, PA, USA.; Autism Impact Fund, Pittsburgh, PA, USA., Pogue-Geile KL; NSABP Foundation, Pittsburgh, PA, USA.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2024 Apr 22; Vol. 26 (1), pp. 69. Date of Electronic Publication: 2024 Apr 22.
Autor:
Advani PP; Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, United States., Ruddy KJ; Department of Oncology, Mayo Clinic, Rochester, MN, United States., Herrmann J; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, United States., Ray JC; Department of Cardiovascular Diseases, Mayo Clinic, Jacksonville, FL, United States., Craver EC; Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, United States., Yothers G; NRG Oncology Statistics and Data Management Center, Pittsburgh, PA, United States.; Department of Biostatistics, The University of Pittsburgh, Pittsburgh, PA, United States., Cecchini RS; NRG Oncology Statistics and Data Management Center, Pittsburgh, PA, United States.; Department of Biostatistics, The University of Pittsburgh, Pittsburgh, PA, United States., Lipchik C; NRG Oncology/NSABP Foundation, Pittsburgh, PA, United States., Feng H; NRG Oncology/NSABP Foundation, Pittsburgh, PA, United States., Rastogi P; NRG Oncology/NSABP Foundation, Pittsburgh, PA, United States.; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States., Mamounas EP; NRG Oncology/NSABP Foundation, Pittsburgh, PA, United States.; Department of Surgical Oncology, Orlando Health Cancer Institute, Orlando, FL, United States., Swain SM; NRG Oncology/NSABP Foundation, Pittsburgh, PA, United States.; Department of Surgical Oncology, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, United States., Geyer CE Jr; NRG Oncology/NSABP Foundation, Pittsburgh, PA, United States.; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States., Wolmark N; NRG Oncology/NSABP Foundation, Pittsburgh, PA, United States.; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States., Paik S; NRG Oncology/NSABP Foundation, Pittsburgh, PA, United States., Pogue-Geile KL; NRG Oncology/NSABP Foundation, Pittsburgh, PA, United States., Colon-Otero G; Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, United States., Perez EA; Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, United States., Norton N; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, United States.
Publikováno v:
Frontiers in oncology [Front Oncol] 2023 May 25; Vol. 13, pp. 1139347. Date of Electronic Publication: 2023 May 25 (Print Publication: 2023).
Autor:
Denkert C; Institute of Pathology, Philipps University Marburg and University Hospital Marburg (UKGM), Marburg, Germany., Lambertini C; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Fasching PA; Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Department of Gynecology and Obstetrics, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Pogue-Geile KL; NSABP Foundation/NRG Oncology, Pittsburgh, Pennsylvania., Mano MS; Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil., Untch M; AGO-B and HELIOS Klinikum Berlin Buch, Berlin, Germany., Wolmark N; NSABP Foundation and University of Pittsburgh/UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania., Huang CS; National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan., Loibl S; German Breast Group, Neu-Isenburg, Germany; Centre for Haematology and Oncology Bethanien, Frankfurt, Germany., Mamounas EP; NSABP Foundation and Orlando Health Cancer Institute, Orlando, Florida., Geyer CE; NSABP Foundation and University of Pittsburgh/UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania., Lucas PC; NSABP Foundation and University of Pittsburgh/UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania., Boulet T; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Song C; Genentech, Inc., South San Francisco, California., Lewis GD; Genentech, Inc., South San Francisco, California., Nowicka M; F. Hoffmann-La Roche Ltd, Basel, Switzerland., de Haas S; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Basik M; NSABP Foundation and Jewish General Hospital, McGill University, Quebec, Canada.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Apr 14; Vol. 29 (8), pp. 1569-1581.